Magazine article from our research archive:
|
|
Bristol-Myers Squibb Finalizes Purchase of Kosan Biosciences.
- Article from:
-
Health & Beauty Close-Up
- Article date:
-
June 29, 2008
|
Copyright informationCOPYRIGHT 2008 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HEALTH AND BEAUTY CLOSE-UP-29 June 2008-Bristol-Myers Squibb Finalizes Purchase of Kosan Biosciences(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com
Bristol-Myers Squibb Company announced that it has completed its previously announced $190 million acquisition of Kosan Biosciences Inc.
As a result of the transaction, Kosan has become a wholly-owned subsidiary of Bristol-Myers Squibb.
Bristol-Myers Squibb initiated a cash tender offer on May 29, to purchase all outstanding common stock of Kosan for $5.50 per share. The tender offer expired at midnight EDT on June 25, at which time approximately 41,449,606 shares, including 1,682,151 shares subject to guaranteed ...
Related newspaper, magazine, and journal articles:
|
Bristol-Myers Squibb to Acquire Kosan Biosciences for 10.33 Times Revenue
Weekly Corporate Growth Report;
June 2, 2008 ;
247 words
...The Deal: Bristol-Myers Squibb Company has entered into...agreement to purchase Kosan Biosciences Inc. for $5.50 per share...shares are tendered, Bristol-Myers will acquire the remaining...for $5.50 per share. Bristol-Myers estimates the transaction...to drug giant ...
|
|
Small Cap Stock Winners - LMLG, KOSN, ULBI, TRMP.
M2 Presswire;
May 30, 2008 ;
700+ words
......52 week low of $0.07. Bristol-Myers Squibb Company (NYSE: BMY) and Kosan Biosciences Inc. (Nasdaq: KOSN) Closed...for the acquisition of Kosan, a cancer therapeutics company, by Bristol-Myers Squibb, for $5.50 per share...epothilones. What They Do: Kosan ...
|
|
Bristol-Myers Squibb and PDL BioPharma Partner to Develop Treatment for...
Health & Beauty Close-Up;
August 22, 2008 ;
581 words
......22 August 2008-Bristol-Myers Squibb and PDL BioPharma...closeupmedia.com Bristol-Myers Squibb Company and PDL...collaboration, Bristol-Myers Squibb would pay PDL BioPharma...development costs, with Bristol-Myers Squibb providing 80 ...
|
 "The Post-Standard (Syracuse, NY)")
|
BRISTOL-MYERS NAMES NEW GENERAL MANAGER.(Business)
The Post-Standard (Syracuse, NY);
July 11, 2008 ;
176 words
...Byline: Charley Hannagan Staff writer Bristol-Myers Squibb Co. Thursday named Nancy Rurkowski general manager...senior director of manufacturing launch planning. The Bristol-Myers Squibb plant in East Syracuse employs 750 workers who research...Since September, Bristol has bought two ...
|
|
|
Kosan Biosciences Inc Added to Bellwether Watch List.
M2 Presswire;
December 20, 2006 ;
700+ words
......Biotech News: Kosan Biosciences Inc Added to Bellwether...RDATE:20122006 Kosan Biosciences Inc (NASDAQ:KOSN...Volume: 410,872 Kosan Biosciences Inc Added to Bellwether...List(NASDAQ:KOSN) Kosan Biosciences is manipulative...cholesterol fighter from ...
|
|
Anti-Cancer Drug Discovery & Development Summit 2002 To Take Place June...
PR Newswire;
March 21, 2002 ;
300 words
......will be comprised of representatives from Pfizer, Bristol-Myers Squibb, Pharmacia, OSI Pharmaceuticals, Amgen, and Genentech...presentations will be given by Aventis, Pharmacia, Novartis, Bristol-Myers Squibb, Abbott Laboratories, Abgenix, Eli Lilly & Co...Ribozyme ...
|
|
|
Current Research on Kosan Biosciences Inc.
M2 Presswire;
January 26, 2007 ;
700+ words
......Current Research on Kosan Biosciences Inc(C)1994-2007...Current Research on Kosan Biosciences Inc (NASDAQ:KOSN) Kosan Biosciences is manipulative...cholesterol fighter from Bristol-Myers Squibb. Kosan targets infectious...date information on Kosan ...
|
|
|
Fundamental Review for Kosan Biosciences Inc.
M2 Presswire;
January 10, 2007 ;
700+ words
......Fundamental Review for Kosan Biosciences Inc(C)1994-2007...Fundamental Review for Kosan Biosciences Inc (NASDAQ:KOSN) Kosan Biosciences is manipulative...cholesterol fighter from Bristol-Myers Squibb. Kosan targets infectious...date information on ...
|
|
|
In-Depth Research on Kosan Biosciences Inc.
M2 Presswire;
January 8, 2007 ;
700+ words
......In-Depth Research on Kosan Biosciences Inc(C)1994-2007...In-Depth Research on Kosan Biosciences Inc (NASDAQ:KOSN) Kosan Biosciences is manipulative...cholesterol fighter from Bristol-Myers Squibb. Kosan targets infectious...date information on Kosan ...
|
|
|
Kosan Biosciences to Present at June Healthcare Conferences.
PR Newswire;
May 27, 2005 ;
388 words
......May 27 /PRNewswire-FirstCall/ -- Kosan Biosciences today announced that Daniel V. Santi...completed for two weeks. About Kosan Kosan Biosciences has two first-in-class anticancer...diseases. For additional information on Kosan Biosciences, please visit the Company's website...
|
|
|
Over 150 Pharma Scientists to Convene at Anti-Cancer Drug Discovery &...
PR Newswire;
June 14, 2002 ;
330 words
......revealing their newest findings. Representatives from Bristol-Myers Squibb, AstraZeneca, Aventis, Merck, Schering-Plough, Hoffmann-...will be given by Aventis, Pharmacia, Bayer, Novartis, Bristol-Myers Squibb, Abbott Laboratories, Abgenix, Eli Lilly & Co...Ribozyme ...
|
See all results.
Or, try our
Advanced Search.
|